We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Genedata Releases a Breakthrough for Genomic Comparison

Genedata Selector™4.0 provides reference-independent genome sequence comparisons while reducing data processing and analysis time to optimize efficiency and save costs.
News

Rare Form: Novel Structures Built from DNA Emerge

DNA, the molecular foundation of life, has new tricks up its sleeve. The four bases from which it is composed can be artificially manipulated to construct endlessly varied forms in two and three dimensions.
News

Illumina Names Sanjay Chikarmane as SVP and General Manager

Chikarmane will report to Illumina President, Francis deSouza.
News

Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results

The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
News

Accurate RNA Dynamics with Beads and Springs

A group of scientists at SISSA proposes a quick alternative for predicting the internal dynamics of RNA molecules (how the different parts move in relation to each other).
News

NIH Study Identifies Gene Variant Linked to Compulsive Drinking

Mice carrying the Met68BDNF gene variant would consume excessive amounts of alcohol.
News

Gene Testing Now Allows Precision Medicine for Thoracic Aneurysms

Researchers at the Aortic Institute at Yale have tested the genomes of more than 100 patients with thoracic aortic aneurysms, a potentially lethal condition, and provided genetically personalized care.
News

Red Wine Antioxidant May Provide New Cancer Therapy Options

Resveratrol and quercetin, two polyphenols that have been widely studied for their health properties, may soon become the basis of an important new advance in cancer treatment,
News

Cellecta Receive Grant to Develop CRISPR Technology

The company has announced the receipt of Phase I SBIR grant funds from the National Institute of Health (NIH) to further its CRISPR-mediated genome-editing program.
News

Study Reveals Improved Way to Interpret High-Throughput Biological Data

A recent study has revealed a novel workflow, identifying associations between molecules to provide insights into cellular metabolism and gene expression in complex biological systems.
Advertisement